Geron Announces PDUFA Date for Imetelstat NDA in Lower Risk MDS

2 years ago

by David Miller

948 Views

Written by David Miller

FOSTER CITY, Calif.–(BUSINESS WIRE) August 22, 2023 — Geron Corporation (Nasdaq: GERN), a late-stage clinical biopharmaceutical company, today announced that the United States Food and Drug Administration (FDA) has assigned a standard review and…Original Article

About the author

David Miller

a pharmacist, a tech enthusiastic, who explored the Internet to gather all latest information pharma, biotech, healthcare and other related industries.

View all posts

[mwai_chat window="true" fullscreen="true"]

You may also like

About the author

David Miller

Don`t Leave Yet!